Korean study keeps close eye on comirnaty vaccine safety
NCT ID NCT06613984
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 28 times
Summary
This study is a safety check for the Comirnaty COVID-19 vaccine in Korean adults. Researchers will track any side effects that happen within a week and up to a month after each dose. The goal is to spot any problems or questions about the vaccine's safety in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 VACCINATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.